14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
TTAM vs CX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Titan America SA (TTAM) captures the overall head-to-head institutional edge over Cemex S.A.B. de C.V. (CX) on higher Unified Composite conviction (52.2/100 HOLD vs. 31.2/100 SELL) after splitting the core matrix 5–4 (led by Valuation Multiples, Profitability & Quality), while CX wins 4–2 across the 6-pillar growth and valuation breakdown. TTAM trades at $11.11 (10.6x Forward P/E, 13.4% operating margin) versus CX at $10.36 (11.6x Forward P/E, 13.3% operating margin).
Growth vs. Quality Trade-Off: TTAM earns the overall head-to-head edge with a stronger Unified Composite Score (52.2/100 HOLD vs. CX 31.2/100 SELL) and 1.78β · 72% Vol risk profile, whereas CX leads top-line expansion (+8.1% YoY revenue growth, 0.11x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: TTAM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.6); meanwhile CX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TTAM vs CX. Trailing 12-month operating profitability (TTAM 13.4% vs CX 13.3%) and valuation multiples (TTAM 10.6x vs CX 11.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Building Materials value chain with $15.2B market capitalization and 13.3% operating margin.
OpEx & R&D Reinvestment20.2% of Rev ($1.30B)
90D Engineering Disclosures0 Published
Investor FAQ TTAM vs CX Key Questions & Quantitative Answers
As of Nov 16, 2026, Titan America SA (TTAM) captures the overall head-to-head institutional edge over Cemex S.A.B. de C.V. (CX) on higher Unified Composite conviction (52.2/100 HOLD vs. 31.2/100 SELL) after splitting the core matrix 5–4 (led by Valuation Multiples, Profitability & Quality), while CX wins 4–2 across the 6-pillar growth and valuation breakdown. TTAM trades at $11.11 (10.6x Forward P/E, 13.4% operating margin) versus CX at $10.36 (11.6x Forward P/E, 13.3% operating margin). Growth vs. Quality Trade-Off: TTAM earns the overall head-to-head edge with a stronger Unified Composite Score (52.2/100 HOLD vs. CX 31.2/100 SELL) and 1.78β · 72% Vol risk profile, whereas CX leads top-line expansion (+8.1% YoY revenue growth, 0.11x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: TTAM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.6); meanwhile CX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CX leads the Growth & Scale pillar: TTAM posts +5.7% YoY revenue growth and -30.4% YoY earnings growth on $1.74B TTM revenue (24.8% gross margin, 13.4% operating margin), compared with CX at +8.1% YoY revenue growth and +55.4% YoY earnings growth on $6.41B TTM revenue (33.5% gross margin, 13.3% operating margin). On trailing 12-month operating scale, TTAM generates $1.74B in USD-normalized revenue versus $6.41B for CX. In operating R&D and SG&A reinvestment, TTAM deploys 11.4% of Rev ($198M) (0 90-day corporate R&D disclosures) versus 20.2% of Rev ($1.30B) (0 disclosures) for CX.
TTAM screens cheaper on headline valuation multiples. TTAM trades at 10.6x Forward P/E, 13.1x Trailing P/E, N/M PEG, and 1.5x EV/Revenue (5.9% FCF margin), whereas CX trades at 11.6x Forward P/E, 65.9x Trailing P/E, 0.11x PEG, and 2.4x EV/Revenue (19.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TTAM (15.1% ROE) versus CX (5.2% ROE) capital efficiency.
In options market volatility and institutional positioning, TTAM carries 104.0% implied volatility (21st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.78β · 72% Vol realized risk). By comparison, CX carries 34.4% implied volatility (70th %ile, Elevated (60th–80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.35β · 33% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.